Dr. Yuxuan Wu trained in the laboratories of Jinsong Li in Chinese Academy of Sciences and Daniel Bauer in Harvard Medical School, where he studied pluripotency of embryonic stem cells, CRISPR mediated genome editing in hematopoietic stem cells. His research program focuses on understanding the molecular mechanisms that regulate self-renewal and differentiation of hematopoietic stem cells, as well as the CRISPR mediated highly efficient gene editing in human hematopoietic stem cells for the beta-thalassemia and sickle cell disease.